Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy

Alama, 1992, Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma, Eur. J. Cancer, 28A, 1079, 10.1016/0959-8049(92)90461-A Annual Report on the Results in Gynecological Cancer, Stockholm: Radiumhemmet, FIGO, 1994, p. 22. Atkin, 1979, Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases, Br. J. Cancer, 40, 210, 10.1038/bjc.1979.168 Awwad, 1992, Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation, Radiother. Oncol., 25, 261, 10.1016/0167-8140(92)90245-P Begg, 1985, A method to measure the duration of DNA synthesis and the potential doubling time from a single sample, Cytometry, 6, 620, 10.1002/cyto.990060618 Begg, 1992, Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: results from the EORTC co-operative trial 22851, Semin. Radiat. Oncol., 2, 22, 10.1016/S1053-4296(05)80046-3 Bolger, 1993, Measurements of cell kinetics in cervical tumours using bromodeoxyuridine, Br. J. Cancer, 68, 1, 166 Cole, 1992, Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis, Br. J. Cancer, 65, 783, 10.1038/bjc.1992.167 Courdi, 1980, Malaise, E.P., 1639 Cox, 1985, Large-dose fractionation, Cancer, 55, 2105, 10.1002/1097-0142(19850501)55:9+<2105::AID-CNCR2820551412>3.0.CO;2-T Davis, 1989, DNA ploidy, grade, and stage in prognosis of uterine cervical cancer, Gynecol. Oncol., 32, 4, 10.1016/0090-8258(89)90840-8 Dixon, 1977, Pre-treatment 3H-TdR labelling of cervical biopsies: histology, staging and tumour response to radiotherapy, Clin. Radiol., 28, 491, 10.1016/S0009-9260(77)80060-3 Dudziński, 1987, DNA content in cervical neoplasia and its relationship to prognosis, Obstet. Gynecol., 69, 373 Dyson, 1987, Flow cytometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours. Radiother. Oncol., 8, 263 Elequin, 1978, Correlation between in vitro labeling indices (LIs) and tumour regression following radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 4, 207, 10.1016/0360-3016(78)90139-6 Gasińska A, Urbański K, Dyba T. DNA ploidy and the labelling index as prognostic factors in cervical cancer. 11th Annual Meeting European Society for Therapeutic Radiology and Oncology, 1992, Malmo, Sweden. Jakobsen, 1984, Prognostic impact of ploidy level in carcinoma of the cervix, Am. J. Clin. Oncol., 7, 475, 10.1097/00000421-198410000-00016 Kaplan, 1958, Non-parametric estimation for incomplete observations, J. Am. Stat. Assoc., 53, 457, 10.1080/01621459.1958.10501452 Lagrange, 1992, The labelling index in carcinoma of the uterine cervix: its correlation with tumour sterilization, Br. J. Radiol., 65, 63, 10.1259/0007-1285-65-769-63 Levine, 1995, Apoptosis, intrinstic radiosensitivity and prediction of radiotherapy response in cervical carcinoma, Radiother. Oncol., 37, 1, 10.1016/0167-8140(95)01622-N Minagawa, 1993, Tumor cell kinetics in elderly patients with cervical cancer, Obstet. Gynecol., 81, 610 Oka, 1996, Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labelling indices, Cancer, 77, 2280, 10.1002/(SICI)1097-0142(19960601)77:11<2280::AID-CNCR15>3.0.CO;2-T Rutgers, 1986, DNA-flow cytometry of squamous cell carcinoma of the human uterine cervix: the identification of prognostically different subgroups, Radiother. Oncol., 7, 249, 10.1016/S0167-8140(86)80036-6 Saunders, 1991, Experience with CHART, Int. J. Radiat. Oncol. Biol. Phys., 21, 871, 10.1016/0360-3016(91)90722-G Steel, 1965, In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical consideration, Eur. J. Cancer, 1, 275, 10.1016/0014-2964(65)90060-5 Strang, 1987, S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix, Anticancer Res., 7, 807 Tsang, 1995, Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results, Int. J. Radiat. Oncol. Biol. Phys., 32, 1319, 10.1016/0360-3016(95)00201-9 Tubiana, 1989, Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival, Radiother. Oncol., 15, 1, 10.1016/0167-8140(89)90113-8 Urbański, 1993, Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial, Eur. J. Gynaecol. Oncol., XIV, 98 West, 1994, Predictive assays in radiation therapy, Adv. Radiat. Biol., 18, 149, 10.1016/B978-0-12-035418-4.50010-7 West, 1997, The independence of intrinsic radiosensitivity as a prognostic factor for patients response to radiotherapy of carcinoma of the cervix, Br. J. Cancer, 76, 1184, 10.1038/bjc.1997.531 Wheeler, 1995, ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 32, 1487, 10.1016/0360-3016(95)00156-S Wilson, 1985, The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry, Cytometry, 6, 641, 10.1002/cyto.990060621 Wilson, 1988, Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry, Br. J. Cancer, 58, 423, 10.1038/bjc.1988.234 Wilson, 1993, Limitations if the bromodeoxyuridine technique for measurement of tumour proliferation, 10.1007/978-3-642-84918-3_3 Wilson, 1995, Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy, Radiother. Oncol., 36, 189, 10.1016/0167-8140(95)01567-Z Zamulaeva, 1966, Prognostic significance of S-phase fraction detected by antithymidine antibodies in epidermoid cervix carcinomas, Int. J. Radiat. Oncol. Biol. Phys., 36, 685, 10.1016/S0360-3016(96)00370-7 Zanetta, 1992, Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma, Gynecol. Oncol., 46, 13, 10.1016/0090-8258(92)90188-O Zolzer, 1995, Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma. Radiother. Oncol., 36, 128